S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
Log in

OTCMKTS:IRSBIris BioTechnologies Stock Price, Forecast & News

$0.04
0.00 (0.00 %)
(As of 08/20/2019)
Add
Compare
Today's Range
$0.04
Now: $0.04
$0.04
50-Day Range
$0.04
MA: $0.04
$0.04
52-Week Range
$0.04
Now: $0.04
$0.41
VolumeN/A
Average Volume8,024 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Iris BioTechnologies, Inc., a life science company, develops solutions for the detection and monitoring of monogenic and complex genomic diseases. It is developing nano-biochip technology platform used for the diagnosis and treatment of patients with breast cancer, neurological disorders, heart diseases, diabetes, and other gene-related metabolic problems. The company also develops BioWindows, an artificial intelligence system, which provides data and analysis for clinical applications, drug development, and stem cell research. Iris BioTechnologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IRSB
Previous SymbolNASDAQ:IRSB
CUSIPN/A
Phone+1-408-8672885

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees7
Next Earnings DateN/A
OptionableNot Optionable

Receive IRSB News and Ratings via Email

Sign-up to receive the latest news and ratings for IRSB and its competitors with MarketBeat's FREE daily newsletter.


Iris BioTechnologies (OTCMKTS:IRSB) Frequently Asked Questions

How has Iris BioTechnologies' stock been impacted by COVID-19 (Coronavirus)?

Iris BioTechnologies' stock was trading at $0.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IRSB stock has increased by 0.0% and is now trading at $0.04. View which stocks have been most impacted by Coronavirus.

How were Iris BioTechnologies' earnings last quarter?

Iris BioTechnologies Inc (OTCMKTS:IRSB) released its quarterly earnings results on Tuesday, November, 15th. The company reported ($0.01) earnings per share for the quarter. View Iris BioTechnologies' earnings history.

Has Iris BioTechnologies been receiving favorable news coverage?

News headlines about IRSB stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Iris BioTechnologies earned a news impact score of -3.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutIris BioTechnologies.

Who are some of Iris BioTechnologies' key competitors?

Who are Iris BioTechnologies' key executives?

Iris BioTechnologies' management team includes the following people:
  • Mr. Simon S. M. Chin MBA, Founder, Chairman, Chief Exec. Officer, Pres, Chief Financial Officer and Sec. (Age 60)
  • Mr. James LeBlanc MBA, VP of Operations (Age 72)
  • Dr. Paul Yaswen Ph.D., Chief Scientific Officer (Age 61)
  • Ms. Grace Osborne MBA, VP of Bus. Devel. & HR and Director (Age 52)
  • Dr. Ronald Mark Gemberling M.D., Chief Medical Officer (Age 72)

What is Iris BioTechnologies' stock symbol?

Iris BioTechnologies trades on the OTCMKTS under the ticker symbol "IRSB."

How do I buy shares of Iris BioTechnologies?

Shares of IRSB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Iris BioTechnologies' stock price today?

One share of IRSB stock can currently be purchased for approximately $0.04.

What is Iris BioTechnologies' official website?

The official website for Iris BioTechnologies is http://www.irisbiotech.com/.

How can I contact Iris BioTechnologies?

Iris BioTechnologies' mailing address is 5201 Great America Pkwy Ste 320, SANTA CLARA, CA 95054-1140, United States. The company can be reached via phone at +1-408-8672885.

This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel